We are live on ! Find out more
ATRC icon

AtriCure

223 hedge funds and large institutions have $1.7B invested in AtriCure in 2025 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 70 increasing their positions, 82 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

209% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 11

11% more funds holding

Funds holding: 201223 (+22)

6% more capital invested

Capital invested by funds: $1.6B → $1.7B (+$94.6M)

1.93% less ownership

Funds ownership: 98.81%96.88% (-1.9%)

15% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 82

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
223
Holders Change
+22
Holders Change %
+10.95%
% of All Funds
2.93%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
34
Increased
70
Reduced
82
Closed
11
Calls
$1.52M
Puts
Net Calls
+$1.52M
Net Calls Change
+$421K
Name Holding Trade Value Shares
Change
Change in
Stake
Massachusetts Financial Services
26
Massachusetts Financial Services
Massachusetts
$15M +$14.6M +424,681 New
WA
27
Wasatch Advisors
Utah
$14.4M -$3.38M -98,067 -19%
Fidelity Investments
28
Fidelity Investments
Massachusetts
$13.9M +$4.26M +123,711 +46%
Two Sigma Advisers
29
Two Sigma Advisers
New York
$12.6M -$3.24M -94,100 -21%
Millennium Management
30
Millennium Management
New York
$12.5M -$234K -6,805 -2%
Connor, Clark & Lunn Investment Management (CC&L)
31
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$12.4M +$3M +86,934 +33%
WCM Investment Management
32
WCM Investment Management
California
$11.4M -$61.2K -1,777 -0.5%
OCM
33
Osterweis Capital Management
California
$11.4M +$226K +6,550 +2%
Voloridge Investment Management
34
Voloridge Investment Management
Florida
$9.65M +$139K +4,041 +1%
PD
35
Point72 (DIFC)
United Arab Emirates
$9.24M +$9.03M +262,065 New
Renaissance Technologies
36
Renaissance Technologies
New York
$9.12M -$4.1M -118,900 -31%
Raymond James Financial
37
Raymond James Financial
Florida
$8.36M -$525K -15,245 -6%
JP Morgan Chase
38
JP Morgan Chase
New York
$8M +$645K +18,716 +9%
State of Wisconsin Investment Board
39
State of Wisconsin Investment Board
Wisconsin
$7.7M -$181K -5,239 -2%
Amundi
40
Amundi
France
$7.62M -$769K -22,317 -9%
PAM
41
Panagora Asset Management
Massachusetts
$7.6M +$24.9K +724 +0.3%
Universal-Beteiligungs- und Servicegesellschaft
42
Universal-Beteiligungs- und Servicegesellschaft
Germany
$7.35M +$255K +7,395 +4%
NC
43
Nicholas Company
Wisconsin
$6.79M
Morgan Stanley
44
Morgan Stanley
New York
$6.66M -$2.18M -63,274 -25%
Adage Capital Partners
45
Adage Capital Partners
Massachusetts
$6.17M -$3.45M -100,000 -36%
Squarepoint
46
Squarepoint
New York
$6.16M -$423K -12,276 -7%
ACM
47
Advisors Capital Management
New Jersey
$6.13M +$168K +4,878 +3%
Bank of New York Mellon
48
Bank of New York Mellon
New York
$5.43M +$70.4K +2,042 +1%
OAM
49
Oberweis Asset Management
Illinois
$5.41M +$5.29M +153,500 New
AG
50
Algert Global
California
$5.18M +$3.13M +90,969 +162%

ATRC Hedge Fund Activity: Q3 2025 in Review

223 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q3 2025, worth a combined $1.7B — up 5.9% from $1.6B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ATRC positions and 11 closed out — a net gain of 23 holders — while 70 added to existing stakes and 82 trimmed.

The largest buyer was Massachusetts Financial Services, opening a new position worth an estimated $14.6M. The largest seller was UBS AM, cutting an estimated $21M.

  • 223 institutional investors held AtriCure (ATRC) as of Q3 2025, up from 201 in Q2 2025.
  • Funds reported $1.7B of AtriCure stock for Q3 2025, up 5.9% quarter-over-quarter.
  • 34 funds opened new AtriCure positions in Q3 2025 and 11 closed out, a net change of +23 holders.
  • The largest AtriCure buyer in Q3 2025 was Massachusetts Financial Services, an estimated $14.6M added.
  • The largest AtriCure seller in Q3 2025 was UBS AM, an estimated $21M sold.

Based on aggregated 13F filings for Q3 2025.